The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Eisai
Stock and Other Ownership Interests - Eisai
Patents, Royalties, Other Intellectual Property - Eisai
Genomic biomarkers of response to lenvatinib/pembrolizumab (Len/Pembro) in patients with advanced renal cell carcinoma.
 
Chung-Han Lee
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Eisai (Inst); Exelixis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Calithera Biosciences; Eisai; Eisai
 
Renzo G. DiNatale
No Relationships to Disclose
 
Diego Chowell
Patents, Royalties, Other Intellectual Property - Personal Genome Diagnostics
 
Chriag Krishna
No Relationships to Disclose
 
Vladimir Makarov
No Relationships to Disclose
 
Natalie Shapnik
No Relationships to Disclose
 
Samuel J. Murray
Travel, Accommodations, Expenses - Exelixis
 
Maria Isabel Carlo
Consulting or Advisory Role - Pfizer
Other Relationship - Prostate Cancer Foundation; Robert Wood Johnson Foundation
 
Martin H Voss
Stock and Other Ownership Interests - CellGenix (I)
Consulting or Advisory Role - Alexion Pharmaceuticals; Calithera Biosciences; Corvus Pharmaceuticals; Eisai; Exelixis; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Takeda
 
Darren R. Feldman
Research Funding - Astellas Pharma; Decibel Therapeutics (Inst); Novartis; Seagen
Other Relationship - UpToDate
 
A. Ari Hakimi
No Relationships to Disclose
 
Yusuke Adachi
Employment - Eisai
Stock and Other Ownership Interests - Eisai
 
Yukinori Minoshima
Employment - Eisai
Stock and Other Ownership Interests - Eisai
 
Junji Matsui
No Relationships to Disclose
 
Yasuhiro Funahashi
Employment - Eisai
Stock and Other Ownership Interests - Eisai
Patents, Royalties, Other Intellectual Property - Eisai
 
Rodolfo F. Perini
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Kenichi Nomoto
Employment - Eisai
Stock and Other Ownership Interests - Eisai
Research Funding - Eisai
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Genentech/Roche; Incyte; Lilly; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); Novartis (Inst); Pfizer (Inst)
 
Timothy An-thy Chan
Leadership - Bristol-Myers Squibb; Cancer Genetics; Illumina
Stock and Other Ownership Interests - Gritstone Bio
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Neoantigen discovery and genomic biomarkers for immunotherapy response